Scope
Description
Colonity reagents required to perform clonality assays for cancer genomic testing.
Contract 1
Supplier
Contract value
- £150,000 excluding VAT
- £180,000 including VAT
Above the relevant threshold
Earliest date the contract will be signed
31 January 2026
Contract dates (estimated)
- 1 February 2026 to 31 January 2027
- 1 year
Main procurement category
Goods
CPV classifications
- 33696100 - Blood-grouping reagents
Contract locations
- UKH12 - Cambridgeshire CC
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - technical reasons
These are specific reagents that are validated for use in the Haem-oncology clonality assays. Invivoscribe Technologies is the sole supplier.
Supplier
Invivoscribe Technologies, SARL
- Public Procurement Organisation Number: PXNH-7642-BTWQ
C/O Ficorec Domiciliation Services, 132, Boulevard Michelet, Hall Nord- 5th etage
Marseille
13008
France
Email: accounting-eu@invivoscribe.com
Website: http://www.invivoscribe.com
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Contract 1
Contracting authority
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
- NHS Organisation Data Service: RGT
- Public Procurement Organisation Number: PPCP-8863-HDGN
Hills Rd
Cambridge
CB2 0QQ
United Kingdom
Email: kevin.macey1@nhs.net
Region: UKH12 - Cambridgeshire CC
Organisation type: Public authority - central government